Taken together, these results indicated that anti-PD-L1 mAb can promote anti-tumor immunity, antigen presentation, T cell activation, and T cell cytotoxicity, and can suppress tumor angiogenesis, growth, invasion, and metastasis. Here, CD274 is linked to neoplasm.